M

Mirum Pharmaceuticals

ASBT inhibitors for rare liver diseases

Vice President - Program Leadership, Launch Products

Product ManagementUpdated on Nov 10
Full-timeFoster City, CA, USANo salary listedHybrid

About the Job

Requirements

  • At least 15 years of experience in the biopharmaceutical industry, including significant experience in commercial strategy, marketing, new product planning, global commercialization, or related leadership roles.
  • Demonstrated success leading global product or lifecycle strategy for marketed or late-stage products, including maximizing product value across indications, geographies, patient populations, and product lifecycle stages.
  • Experience developing product strategy, positioning, forecasting, market development, launch planning, competitive strategy, and long-range commercial plans.
  • A global mindset and ability to incorporate U.S. and international market needs and perspectives into product strategy and investment decisions.
  • Significant experience leading senior cross-functional teams across Commercial, Development, Medical Affairs, Regulatory, Market Access, CMC/Technical Operations, Finance, and other functions, including leadership through influence without direct authority.
  • Ability to operate as an enterprise product leader, integrating commercial, clinical, regulatory, medical, technical, and financial perspectives into a cohesive product strategy.
  • Strategic and financial acumen, including experience developing business cases, evaluating investment alternatives, understanding product profit-and-loss statements and forecasts, and making resource-allocation recommendations.
  • Track record of making effective decisions amid complexity, uncertainty, competing priorities, and cross-functional trade-offs.
  • Strong understanding of the global biopharmaceutical commercialization environment, including clinical evidence, regulatory strategy, market access, pricing and reimbursement, competitive dynamics, and commercial execution.
  • Ability to influence and align senior executives and functional leaders, constructively challenge assumptions, resolve differences, and drive teams toward clear decisions and execution.
  • Ability to synthesize complex information into clear strategic choices and recommendations for executive leadership and governance bodies.
  • Strong orientation toward patient impact and value creation, balancing near-term business performance with investments that maximize long-term product potential.
  • Bachelor’s degree required.

Responsibilities

  • Define and execute integrated global lifecycle strategy for assigned products, establishing long-term vision and value-maximization plans while accounting for risks, trade-offs, and value.
  • Identify and prioritize opportunities across geographies, indications, patient segments, formulations, evidence generation, regulatory pathways, and other lifecycle initiatives.
  • Reassess product strategy based on emerging clinical data, competitive developments, market dynamics, regulatory changes, product performance, and intellectual property considerations.
  • Lead the cross-functional Program Team, including representatives from U.S. and international Commercial, Development, Regulatory, Medical Affairs, CMC/Technical Operations, Market Access, Finance, Legal, and other functions.
  • Evaluate geographic expansion opportunities and commercialization models, including direct entry, distributors, partnerships, and licensing, in collaboration with regional commercial leaders.
  • Lead evaluation of new indications, expanded patient populations, label enhancements, combination strategies, and other development opportunities.
  • Drive cross-functional decision-making and ensure key trade-offs and internal resource constraints are identified, evaluated, and resolved.
  • Rationalize, obtain endorsement for, and manage the Program Team budget with Finance and other cross-functional leaders as part of annual long-range planning.
  • Lead through influence across senior cross-functional stakeholders and create accountability across organizational boundaries.
  • Balance commercial opportunity with scientific, regulatory, operational, and financial considerations, making explicit strategic choices and trade-offs.
  • Prioritize lifecycle opportunities and investments based on patient impact, strategic fit, value creation, probability of success, investment requirements, and organizational capacity.
  • Develop and communicate business cases, investment recommendations, and strategic scenarios to executive leadership and governance committees to support timely decisions and resource allocation.
  • Translate complex information into clear recommendations and decisions.
  • Maintain a global, long-term perspective while driving near-term execution.
  • Represent the program and company externally with thought leaders, prospective partners, and other stakeholders.

Desired Qualifications

  • Prior experience in rare disease and/or specialty pharmaceuticals.
  • An MBA or other advanced degree.

About the Company

Mirum Pharmaceuticals

ASBT inhibitors for rare liver diseases

Mirum develops therapies for rare liver diseases, led by LIVMARLI (maralixibat), an oral ASBT inhibitor that reduces bile acid buildup and itching in Alagille syndrome and other cholestatic conditions. It is pursuing LIVMARLI for additional rare diseases such as PFIC and biliary atresia and developing volixibat for primary sclerosing cholangitis and primary biliary cholangitis. The company combines drug development with commercialization in the United States and other major markets, working with physicians, payers, and patient groups to improve access. Its goal is to bring effective therapies to patients with rare liver diseases and build a sustainable commercial presence in key markets.

Company size
501-1,000
Company stage
IPO
Headquarters
Foster City, CA
Founded
2018

Recently Posted Jobs

Explore more opportunities at Mirum Pharmaceuticals

See more jobs